What is he best known for?
The fields of study he is best known for:
- Antibiotics
- Bacteria
- Staphylococcus aureus
Rodrigo E. Mendes mostly deals with Microbiology, Staphylococcus aureus, Broth microdilution, Linezolid and 23S ribosomal RNA.
His study looks at the relationship between Microbiology and topics such as Klebsiella pneumoniae, which overlap with Enterobacteriaceae.
His Staphylococcus aureus research is multidisciplinary, incorporating elements of Enterococcus faecium and Antibiotic resistance.
His Broth microdilution research includes elements of Viridans streptococci, Acinetobacter, Pseudomonas aeruginosa, Ceftazidime and Meropenem.
His work deals with themes such as Tigecycline, Staphylococcus epidermidis and Potency, which intersect with Linezolid.
The study incorporates disciplines such as Amikacin, Vancomycin and Levofloxacin in addition to Tigecycline.
His most cited work include:
- Early Dissemination of NDM-1- and OXA-181-Producing Enterobacteriaceae in Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007 (290 citations)
- First Report of cfr-Mediated Resistance to Linezolid in Human Staphylococcal Clinical Isolates Recovered in the United States (193 citations)
- Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program. (150 citations)
What are the main themes of his work throughout his whole career to date?
Rodrigo E. Mendes mainly focuses on Microbiology, Staphylococcus aureus, Linezolid, Broth microdilution and Antimicrobial.
Rodrigo E. Mendes works in the field of Microbiology, focusing on Streptococcus pneumoniae in particular.
His Staphylococcus aureus study incorporates themes from In vitro and Drug resistance.
His biological study spans a wide range of topics, including Enterococcus, Daptomycin, Teicoplanin and Staphylococcus epidermidis.
His study in Broth microdilution is interdisciplinary in nature, drawing from both Tigecycline, Antibacterial agent and Meropenem.
The various areas that Rodrigo E. Mendes examines in his Antimicrobial study include Cephalosporin, Levofloxacin, Antibiotic resistance and Escherichia coli.
He most often published in these fields:
- Microbiology (83.71%)
- Staphylococcus aureus (32.25%)
- Linezolid (25.73%)
What were the highlights of his more recent work (between 2018-2021)?
- Microbiology (83.71%)
- Antimicrobial (22.48%)
- Staphylococcus aureus (32.25%)
In recent papers he was focusing on the following fields of study:
Microbiology, Antimicrobial, Staphylococcus aureus, Broth microdilution and Sentry are his primary areas of study.
His biological study focuses on Meropenem.
His Antimicrobial research is multidisciplinary, relying on both Infective endocarditis, Lipoglycopeptide, Staphylococcus saprophyticus, Cephalosporin and Antibiotic resistance.
The Staphylococcus aureus study combines topics in areas such as Clindamycin, In vitro and Streptococcus pneumoniae.
His Sentry research incorporates themes from Antimicrobial susceptibility and Pathogen.
His studies in Linezolid integrate themes in fields like Enterococcus and Teicoplanin.
Between 2018 and 2021, his most popular works were:
- The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program. (59 citations)
- Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among Enterobacteriaceae Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program (35 citations)
- Temporal and Geographic Variation in Antimicrobial Susceptibility and Resistance Patterns of Enterococci: Results From the SENTRY Antimicrobial Surveillance Program, 1997-2016. (28 citations)
In his most recent research, the most cited papers focused on:
- Antibiotics
- Bacteria
- Antibiotic resistance
Rodrigo E. Mendes mainly investigates Microbiology, Broth microdilution, Sentry, Antimicrobial and Staphylococcus aureus.
His Microbiology research is multidisciplinary, incorporating perspectives in Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterobacteriaceae.
His Sentry study combines topics in areas such as Streptococcus pneumoniae and Public health.
His research investigates the connection with Antimicrobial and areas like Antibiotic resistance which intersect with concerns in Drug development, Infection control and Clinical trial.
When carried out as part of a general Staphylococcus aureus research project, his work on Methicillin-resistant Staphylococcus aureus is frequently linked to work in In vitro diagnostic, therefore connecting diverse disciplines of study.
His research integrates issues of Enterococcus faecalis and Enterococcus faecium in his study of Vancomycin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
